A Cross-Sectional Study of Psychiatric Manifestations Following Oseltamivir Administration for Suspected Patients with H1N1 Swine Influenza Infection
Introduction: Oseltamivir is an antiviral drug used to treat H1N1 influenza. FDA added a warning to the label of oseltamivir drawing attention to the risk of developing neuropsychiatric adverse events. There are some case reports reported psychiatric symptoms on oseltamivir intake. However, data is...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mashhad University of Medical Sciences
2022-03-01
|
| Series: | Journal of Cardio-Thoracic Medicine |
| Subjects: | |
| Online Access: | https://jctm.mums.ac.ir/article_19832_57ba3d48b9f94f5c982cc3fbcb2974f2.pdf |